Resources

Researchers at the ADA reported that Liraglutide reverses prediabetes indices in most obese patients with existing prediabetes …Full Story

Lower hemoglobin A1c levels alone don’t appear to increase mortality risk with intensive glucose control, subanalyses of two major diabetes trials revealed. Each 1% lower average HbA1c was associated with a 56% lower relative risk of mortality. Diabetes patients had reduced composite cardiovascular event and mortality rates with intensive glucose …

If you are pregnant and your mate complains your frequent snoring is rattling the bedroom windows, you may have bigger problems than an annoyed, sleep-deprived partner

Diabetic patients with poor glycemic control or vascular or neuropathic complications may also suffer from hearing loss. All patients with hemoglobin A1c levels greater than 7% had hearing impairment.

Saxagliptin, an investigational dipeptidyl peptidase-4 (DPP4) inhibitor, may offer cardioprevention as a side benefit of diabetes treatment, according to a meta-analysis.

Aleglitazar, a novel dual peroxisome proliferator-activated receptor (PPAR) agonist, is effective for glucose control in Type 2 diabetes and reduces A1c 1.3%.

Insulin sensitivity, beta-cell function, and blood glucose may provide telltale signs of impending Type 2 diabetes up to five years before onset, researchers affirmed.

For diabetic retinopathy screening, telemedicine and photographing fewer fields allow for faster detection for more patients, researchers said.

After two decades on the rise, retinopathy now affects more than a third of all diabetes patients, according to the latest nationally representative estimate.

A novel continuous glucose monitor that uses fluorescence to provide a read-out of blood sugar appears to be accurate, especially in the hypoglycemic range, researchers said at ADA.